Program at a Glance

  • Thursday, March 14, 2019
  • Friday, March 15, 2019
  • Saturday, March 16, 2019

Thursday, March 14, 2019

* Session Code

JSJoint Symposium

ASAsian Hematology Symposium

SSScientific Session

LSLuncheon Symposium

ESEducation Session (This sessions will be provided with simultaneous interpretation in Korean.)

Time VISTA 1 VISTA 2 VISTA 3 Grand Hall
08:00-09:00 Registration
09:00 Opening Remark
09:00 - 10:30 [JS01] KAI-KSH Joint Symposium
- Immunotherapeutics in Blood Disease
[SS01] Bone Marrow Failure
Immune Checkpoint Inhibitor in Cancer
(Seung-Woo Lee, Korea)

CAR-T
(Chan Hyuk Kim, Korea)

Cytotoxic T Lymphocyte Therapy
(Hyewon Lee, Korea)

Immune Checkpoint Inhibitor in Lymphoma
(Dok Hyun Yoon, Korea)
TBD
(Nack-Gyun Chung, Korea)

  Germ Line Mutations in Inherited BM Failure
(Jean Soulier, France)

Telomere Length and Somatic Mutations in APlastic Anaemia
(Dong Soon Lee, Korea)
10:30 - 10:45 Coffee Break
10:45- 11:45 Plenary Lecture I - Gene Therapy in Hematology
Application of CRISPR/Cas-9 in blood dz
(Matthew H. Porteus, USA)

Gene therapy in Hemophilia
(Katherine High, USA)
11:45- 12:45 Presidential Symposium
Stem cells in AML
(Ravindra Majeti, USA)

Optimal Treatment of Adolescents and Young Adult ALL
(Ching-Hon Pui, USA)
12:45 - 13:40 [LS01] [LS02] [LS03]
TBD TBD TBD
13:40 - 14:40 [AS01] Asian Hematology Symposium [AS02] Asian Hematology Symposium
TBD TBD
14:40 - 14:55 Coffee Break
14:55 - 16:25 [JS02] KOGO-KSH Joint Symposium - Genomics for Precision Hematology [SS02] Multiple Myeloma: How is MM Developed and Progressed? From 3 Different Viewpoint [SS03] Transplantation/Cell Therapy [ES01] Iron Metabolism
Understanding angioimmunoblastic T-cell lymphoma: From genomics to animal pathology
(Jaesang Kim, Korea)

Genomic Pathogenesis of Epstein–Barr virus (EBV)- Induced Diffuse Large B Cell Lymphoma
(Sung-Yup Cho, Korea)

Current Status of Precision Hematology
(Young-Uk Cho, Korea)

Clinical application of Precision hematology
(Joon-Ho Moon, Korea)
High Risk MM Identifyed by Genomic Analysis
(Gareth Morgan, UK)

What Role does Bone Marrow Microenvironment Play on MM Cells
(Yusuke Furukawa, Japan)

Antigen-mediated Regulation in MM
(Madhav Dhodapkar, USA)
TK cell Therapy
(Chiara Bonini, Italy)

Updates on CAR T cell Therapy for
Relapsed/refracoty MM (Jesús Berdeja, USA)

New Insights into Cancer Vaccine Strategies
(Larry Kwak, USA)
Iron Metabolism in Hemoglobinopathies
(Vip Viprakasit, Thailand)

Deferasirox for Iron Overload Patients: Preserving Organ Functions
(Norbert Gattermann, Germany)

Managing Side Effects in Iron Chelation Therapy
(Heather Leitch, Canada)
16:25 - 16:40 Break
16:40 - 18:10 [SS04] Myeloproliferative Neoplasm [SS05] Bleeding Disorder/Thrombosis [SS06] Pediatric Disease: Inherited hematologic malignancies [ES02] Indolent Lymphoma: From Genetics to the Clinic
Clinical Significance of Genetic Stratification of MPN Patients
(Robert Kralovics , Austria)

Molecular Mechanism of MPN Development by Mutant Calreticulin
(Norio Komatsu, Japan)

Interferon Treatment for MPN
(Jean-Jacques Kiladjian, France)
Gene Therapy for Hemophilia
(Glenn F. Pierce, USA)

Individualized Treatment for Hemophilia : Population Pharmacokinetics Approach
(Cindy Yeung, Canada)

Mechanisms of cancer-associated thrombosis
(Nigel Mackman, USA)
Identification of Germline Predisposition
(Lucy Godley, USA)

GATA2 Leukemogenesis
(Jean Donadieu, France)

Monosomy 7/SAMD9 Related Disorder and Familial AML/MDS
(Hirotaka Matsui, Japan)
Mantle Cell Lymphoma
(Mats Jerkeman, Sweden)

Follicular Lymphoma
(Gilles Salles , France)

Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
(Wei Xu, China)
18:10 - 18:30 Break
18:30 - 20:00 Welcome Reception